← Back to Search

Dietary Supplement

Prenatal Supplements for Male Infertility

N/A
Recruiting
Led By Dan Nayot, BSc, MSc, MD
Research Sponsored by The Bird and Be Co Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up a repeat semen analysis will be performed 3 months after power prenatal for sperm intervention
Awards & highlights

Study Summary

This trial studies a male fertility supplement to see if it improves sperm quality in men with infertility.

Who is the study for?
Men aged 18-45 with recent poor sperm quality (low count, motility, or morphology) and experiencing infertility can join this trial. They must not have a varicocele, be taking antioxidants other than multivitamins, or be outside the age range.Check my eligibility
What is being tested?
The trial is testing 'Power Prenatal for Sperm', a supplement aimed at improving sperm quality over a 90-day course. Participants' semen will be analyzed before and after to assess any changes in sperm health.See study design
What are the potential side effects?
While specific side effects are not listed for 'Power Prenatal for Sperm', supplements may cause digestive discomfort, allergic reactions, or interact with other medications.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~a repeat semen analysis will be performed 3 months after power prenatal for sperm intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and a repeat semen analysis will be performed 3 months after power prenatal for sperm intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sperm Progressive Motility (Semen Analysis); as percentage (%)
Secondary outcome measures
Sperm Concentration (Semen Analysis); as millions / mL
Sperm Morphology (Semen Analysis); as percentage (%)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Power Prenatal for SpermExperimental Treatment1 Intervention
This is a single arm study. Participants will take supplements for 3 months. The supplements is Power Prenatal for Sperm (active ingredients - https://birdandbe.com/the-power-prenatal-for-sperm)

Find a Location

Who is running the clinical trial?

The Bird and Be Co IncLead Sponsor
1 Previous Clinical Trials
174 Total Patients Enrolled
Dan Nayot, BSc, MSc, MDPrincipal InvestigatorThe Bird and Be Co
1 Previous Clinical Trials
174 Total Patients Enrolled

Media Library

Power Prenatal for Sperm (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05410782 — N/A
Male Infertility Research Study Groups: Power Prenatal for Sperm
Male Infertility Clinical Trial 2023: Power Prenatal for Sperm Highlights & Side Effects. Trial Name: NCT05410782 — N/A
Power Prenatal for Sperm (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05410782 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals of legal age being accepted for this clinical investigation?

"As mandated by the trial's inclusion criteria, applicants must be between 18 and 45 years old."

Answered by AI

Who meets the eligibility criteria for participation in this clinical experiment?

"To qualify for this study, applicants must suffer from male infertility and be in the 18-45 year old age bracket. The team is currently accepting up to 50 participants."

Answered by AI

Are there any openings for this research project at the moment?

"As of today, this trial is actively recruiting participants. Initially posted on April 1st 2022 and recently updated August 20th 2023, the study requires volunteers to participate."

Answered by AI

How many participants are being monitored for this experiment?

"Affirmative. According to the clinicaltrials.gov webpage, this study was initially posted on April 1st 2022 and is still actively seeking patients as of August 20th 2021. This trial targets 50 participants from a single medical centre."

Answered by AI
~17 spots leftby Apr 2025